Yael Margolin

Yael Margolin currently works at Ramot at Tel Aviv University Ltd., as Director from 2020, Scinai Immunotherapeutics Ltd., as Director, Purple Biotech Ltd., as Independent Director from 2023, Tau Ventures Ltd., as Director, Gamida Cell, Inc., as President, and Welltech Ventures, as Advisory Board Member.
Dr. Margolin also formerly worked at Gamida Cell Ltd., as President & Director from 2017 to 2019, Collgard Biopharmaceuticals Ltd., as Director, Scinai Immunotherapeutics Ltd., as Independent Director, POINT Biopharma Global, Inc., as Independent Director from 2021 to 2023, Quris Technologies Ltd., as Director, Makesense Digital Health Ltd., as Director, Teva Pharmaceuticals USA, Inc., as Program Manager from 1992 to 1998, Denali Ventures LLC, as Vice President, and Yale School of Medicine, as Associate from 1987 to 1991.
Dr. Margolin received her undergraduate degree and graduate degree from Tel-Aviv University and doctorate degree from Weizmann Institute of Science.